Business Description
Bacil Pharma Ltd
ISIN : INE711D01018
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 11.53 | |||||
Equity-to-Asset | 0.97 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.33 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 31.7 | |||||
3-Year EPS without NRI Growth Rate | -38.4 | |||||
3-Year FCF Growth Rate | 27.6 | |||||
3-Year Book Growth Rate | -7.4 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 13.88 | |||||
9-Day RSI | 34.28 | |||||
14-Day RSI | 49.16 | |||||
6-1 Month Momentum % | 215.02 | |||||
12-1 Month Momentum % | 207.57 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 9.68 | |||||
Quick Ratio | 9.68 | |||||
Cash Ratio | 8.89 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 0.07 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -7.9 | |||||
ROA % | -7.66 | |||||
ROIC % | -19.39 | |||||
ROC (Joel Greenblatt) % | -518.28 | |||||
ROCE % | -8.05 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 9.77 | |||||
Price-to-Tangible-Book | 9.78 | |||||
EV-to-EBIT | -122.7 | |||||
EV-to-EBITDA | -125.56 | |||||
EV-to-FCF | -85.27 | |||||
Price-to-Net-Current-Asset-Value | 35.57 | |||||
Price-to-Net-Cash | 38.92 | |||||
Earnings Yield (Greenblatt) % | -0.83 | |||||
FCF Yield % | -1.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Bacil Pharma Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | |||
EPS (TTM) (₹) | -0.16 | ||
Beta | 1.22 | ||
Volatility % | 84.14 | ||
14-Day RSI | 49.16 | ||
14-Day ATR (₹) | 0.421832 | ||
20-Day SMA (₹) | 22.1545 | ||
12-1 Month Momentum % | 207.57 | ||
52-Week Range (₹) | 4.71 - 24.66 | ||
Shares Outstanding (Mil) | 5.89 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Bacil Pharma Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Bacil Pharma Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Bacil Pharma Ltd Frequently Asked Questions
What is Bacil Pharma Ltd(BOM:524516)'s stock price today?
When is next earnings date of Bacil Pharma Ltd(BOM:524516)?
Does Bacil Pharma Ltd(BOM:524516) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |